Task: Answer the multiple choice question.
Query: Which drug exhibits a -4.578% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) C=CCn1cc(C(=O)N2CCN(CC)CC2)c(=O)c2cc(S(=O)(=O)N(CC)CC)ccc21
b) CCC(c1nnc(SCC(=O)NCC2CCCO2)n1Cc1ccccc1)N(C)C
Answer: b. CCC(c1nnc(SCC(=O)NCC2CCCO2)n1Cc1ccccc1)N(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(c1nnc(SCC(=O)NCC2CCCO2)n1Cc1ccccc1)N(C)C
CCC(c1nnc(SCC(=O)NCC2CCCO2)n1Cc1ccccc1)N(C)C
2-[[4-benzyl-5-[1-(dimethylamino)propyl]-1,2,4-triazol-3-yl]sulfanyl]-N-(oxolan-2-ylmethyl)acetamide